Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Cell+Rep+Med 2021 ; 2 (6): 100291 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection #MMPMID33977279
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bezier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadie JM; Cogne M; Tarte K
Cell Rep Med 2021[Jun]; 2 (6): 100291 PMID33977279show ga
Acute respiratory distress syndrome (ARDS) is the main complication of coronavirus disease 2019 (COVID-19), requiring admission to the intensive care unit (ICU). Despite extensive immune profiling of COVID-19 patients, to what extent COVID-19-associated ARDS differs from other causes of ARDS remains unknown. To address this question, here, we build 3 cohorts of patients categorized in COVID-19(-)ARDS(+), COVID-19(+)ARDS(+), and COVID-19(+)ARDS(-), and compare, by high-dimensional mass cytometry, their immune landscape. A cell signature associating S100A9/calprotectin-producing CD169(+) monocytes, plasmablasts, and Th1 cells is found in COVID-19(+)ARDS(+), unlike COVID-19(-)ARDS(+) patients. Moreover, this signature is essentially shared with COVID-19(+)ARDS(-) patients, suggesting that severe COVID-19 patients, whether or not they experience ARDS, display similar immune profiles. We show an increase in CD14(+)HLA-DR(low) and CD14(low)CD16(+) monocytes correlating to the occurrence of adverse events during the ICU stay. We demonstrate that COVID-19-associated ARDS displays a specific immune profile and may benefit from personalized therapy in addition to standard ARDS management.